Total Valuation
Genprex has a market cap or net worth of $4.25M. The enterprise value is -$17.26M.
Market Cap$4.25M
Enterprise Value-$17.26M
Share Statistics
Genprex has 504,935 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding504,935
Owned by Insiders16.93%
Owned by Institutions―
Financial Efficiency
Genprex’s return on equity (ROE) is -2.04 and return on invested capital (ROIC) is -194.32%.
Return on Equity (ROE)-2.04
Return on Assets (ROA)-1.60
Return on Invested Capital (ROIC)-194.32%
Return on Capital Employed (ROCE)-1.94
Revenue Per Employee0.00
Profits Per Employee-1.25M
Employee Count13
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Genprex is ―. Genprex’s PEG ratio is 0.00108.
PE Ratio―
PS Ratio0.00
PB Ratio0.21
Price to Fair Value0.21
Price to FCF-0.11
Price to Operating Cash Flow-0.17
PEG Ratio0.00108
Income Statement
In the last 12 months, Genprex had revenue of 0.00 and earned -16.23M in profits. Earnings per share was -382.80.
Revenue0.00
Gross Profit0.00
Operating Income-15.52M
Pretax Income-16.23M
Net Income-16.23M
EBITDA-15.49M
Earnings Per Share (EPS)-382.80
Cash Flow
In the last 12 months, operating cash flow was -14.29M and capital expenditures 0.00, giving a free cash flow of -14.29M billion.
Operating Cash Flow-14.29M
Free Cash Flow-14.29M
Free Cash Flow per Share-28.30
Dividends & Yields
Genprex pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-1.30
52-Week Price Change-97.50%
50-Day Moving Average13.41
200-Day Moving Average63.18
Relative Strength Index (RSI)32.29
Average Volume (3m)45.83M
Important Dates
Genprex upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Genprex as a current ratio of 3.84, with Debt / Equity ratio of 0.00%
Current Ratio3.84
Quick Ratio3.84
Debt to Market Cap0.00
Net Debt to EBITDA0.51
Interest Coverage Ratio-20.97
Taxes
In the past 12 months, Genprex has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Genprex EV to EBITDA ratio is 0.40, with an EV/FCF ratio of 0.40.
EV to Sales0.00
EV to EBITDA0.40
EV to Free Cash Flow0.40
EV to Operating Cash Flow0.40
Balance Sheet
Genprex has $18.05M in cash and marketable securities with $0.00 in debt, giving a net cash position of $18.05M billion.
Cash & Marketable Securities$18.05M
Total Debt$0.00
Net Cash$18.05M
Net Cash Per Share$35.75
Tangible Book Value Per Share$187.79
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Genprex is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast93.80%